| Lobbyist Public Search |
|
Records prior to registration year 2005 are not available online.
Contact the Lobbyist Division here for assistance.
|
Search data is collected from registration records and disclosure reports
submitted by lobbyists, lobbying entities, and their clients. Massachusetts General Law requires any party providing or retaining
lobbying services to register annually, and submit disclosure reports twice a year.
|
| Your comments are welcome:
submit feedback
|
|
| Disclosure reporting details |
|
Back to search detail summary
|
|
:
01/01/2025 - 06/30/2025
|
|
Authorizing Officer name
|
John
F.X.
Heffernam
|
|
Title
|
Principal
|
|
Business name
|
Park Street Strategies, LLC
|
|
Address
|
121 Mount Vernon Street
|
|
City, state, zip code
|
Boston, MA 02108
|
|
Country
|
US
|
|
Phone
|
617-981-0015
|
|
|
|
|
Client Compensation
|
| Acuity Strategic Partners LLC |
$50,000.00
|
| Amgen Inc. |
$36,000.00
|
| NanoDx, Inc |
$0.00
|
| Acadia Pharmaceuticals Inc. |
$30,000.00
|
| Massachusetts Biotechnology Council, Inc |
$60,000.00
|
| Sage Therapeutics, Inc. |
$33,000.00
|
| UCB, Inc. |
$27,500.00
|
| Biotechnology Innovation Organization |
$29,500.00
|
| PTC Therapeutics |
$0.00
|
| Total salaries received |
$266,000.00
|
|
|
| |
|
Compensation/Salaries Paid
|
|
John F.X. Heffernan
|
$117,000.00
|
| Total salaries paid |
$117,000.00
|
|
| |
|
Activities, Bill Numbers and Titles
|
| No activities, bill numbers or bill titles were disclosed for this reporting period. |
|
| |
|
Operating Expenses
|
| 03/12/2025 |
Ward & Lawless LLC, compliance support services
|
Other operating expenses
|
$1,031.25
|
| 02/01/2025 |
Staples
|
Photocopies, scans
|
$37.71
|
| 02/10/2025 |
Greater Boston Chamber
|
Professional dues
|
$365.00
|
| 06/30/2025 |
Meeting House Office & Retail
|
Internet fees
|
$300.00
|
| 06/30/2025 |
Meeting House Office & Retail
|
Rent
|
$7,240.66
|
| 06/30/2025 |
AT&T
|
Telephone, cell phone, handheld
|
$726.54
|
| | | Total operating expenses |
$9,701.16
|
|
| |
|
Meals, Travel, and Entertainment Expenses
|
| 01/08/2025 | Park Street Strategies, LLC |
Travel
|
Laz Parking, for parking
|
John Heffernan
|
$40.00
|
| 01/21/2025 | Park Street Strategies, LLC |
Travel
|
Laz Parking, for parking
|
John Heffernan
|
$45.00
|
| 02/20/2025 | Park Street Strategies, LLC |
Travel
|
Laz Parking, for parking
|
John Heffernan
|
$40.00
|
| 03/13/2025 | Park Street Strategies, LLC |
Travel
|
Laz Parking, for parking
|
John Heffernan
|
$40.00
|
| 03/26/2025 | Park Street Strategies, LLC |
Travel
|
Laz Parking, for parking
|
John Heffernan
|
$15.00
|
| 04/11/2025 | Park Street Strategies, LLC |
Travel
|
Laz Parking, for parking
|
John Heffernan
|
$15.00
|
| 04/17/2025 | Park Street Strategies, LLC |
Travel
|
Laz Parking, for parking
|
John Heffernan
|
$15.00
|
| 04/28/2025 | Park Street Strategies, LLC |
Travel
|
Laz Parking, for parking
|
John Heffernan
|
$40.00
|
| 05/21/2025 | Park Street Strategies, LLC |
Travel
|
Laz Parking, for parking
|
John Heffernan
|
$40.00
|
| | | | | Total amount |
$290.00
|
|
| |
|
Additional Expenses
|
| No additional expenses were filed for this disclosure reporting period. |
|
| |
|
Campaign Contributions
|
| No campaign contributions were filed for this disclosure reporting period. |
|
| |
|
Lobbyist: John F.X. Heffernan
|
|
Executive
|
Other
|
No lobbying activities conducted.
|
Neutral
|
$0.00
|
N/A
|
| | | |
Total amount
|
$0.00
| |
|
|
Lobbyist: John F.X. Heffernan
|
|
Executive
|
Massachusetts Economic Development & Finance Agency (MassDevelopment)
|
Contacts with Massachusetts Life Sciences Center regarding tax incentives related to relocation and job growth in Massachusetts.
|
Support
|
$0.00
|
N/A
|
| | | |
Total amount
|
$0.00
| |
|
|
Lobbyist: John F.X. Heffernan
|
|
Client:
Massachusetts Biotechnology Council, Inc
|
|
|
|
House Bill
|
785
|
An Act protecting 340B contract pharmacies
|
Oppose
|
$0.00
|
N/A
|
|
House Bill
|
1101
|
An Act relative to consumer deductibles
|
Support
|
$0.00
|
N/A
|
|
Senate Bill
|
1514
|
An Act relative to provider choice
|
Support
|
$0.00
|
N/A
|
|
Executive
|
Executive Office of Housing and Economic Development (EOHED)(Executive Office of Health and Human Services)
|
Initiatives in the life sciences industry around workforce training, investment tax credits, economic development incentive programs, R&D Tax credits, financing and Infrastructure grants. Massachusetts Life Sciences Center initiatives around internship programs, tax incentive programs, seed funding, and capital project grants.
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
868
|
An Act enhancing health care market oversight and pharmaceutical access
|
Oppose
|
$0.00
|
N/A
|
|
House Bill
|
1080
|
An Act relative to copay assistance
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
847
|
An Act relative to rapid whole genome sequencing
|
Support
|
$0.00
|
N/A
|
|
House Bill
|
4003
|
An Act making appropriations for fiscal year 2025 to provide for supplementing certain existing appropriations and for certain other activities and projects
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
848
|
An Act relating to covered entity reporting to increase accountability to safeguard benefit for vulnerable patients
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
4043
|
An Act relative to copay assistance for medications
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
2384
|
An Act relative to provider choice
|
Support
|
$0.00
|
N/A
|
|
Executive
|
Executive Office of Labor and Workforce Development (EOLWD)
|
Initiatives around workforce training in the life sciences industry, including but not limited to non-four-year degree pathways with hands-on experience, partnerships with minority serving Institutions, increasing career awareness in younger students, and centralizing workforce development efforts.
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
1364
|
An Act relative to promoting healthcare access and affordability for patients
|
Support
|
$0.00
|
N/A
|
|
Senate Bill
|
827
|
An Act to ensure access to prescription medications
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
884
|
An Act to define modest meals and refreshments in prescriber education settings
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
4001
|
An Act making appropriations for the fiscal year 2026 for the maintenance of the departments, boards, commissions, institutions, and certain activities of the commonwealth, for interest, sinking fund, and serial bond requirements, and for certain permanent improvements
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
1167
|
An Act to enact pharmacy benefit manager duties
|
Support
|
$0.00
|
N/A
|
|
House Bill
|
1384
|
An Act updating the health care cost growth benchmark and associated market oversight activities
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
693
|
An Act relative to non-medical switching
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
1082
|
An Act to enact the pharmacy benefit manager compensation reform
|
Support
|
$0.00
|
N/A
|
|
Senate Bill
|
698
|
An Act relative to consumer deductibles
|
Support
|
$0.00
|
N/A
|
|
House Bill
|
1125
|
An Act relative to non-medical switching
|
Neutral
|
$0.00
|
N/A
|
|
Executive
|
Office of the Governor
|
Regulations or policies pertaining to drug innovation, pharmaceuticals, recycling and disposal, provider and industry practices related to pharmaceuticals, drug pricing, drug transparency, prescribing, dispensing and monitoring controlled substances and related policies, patient access and prescribing.
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
724
|
An Act promoting healthcare access and affordability for patients
|
Support
|
$0.00
|
N/A
|
|
House Bill
|
1324
|
An Act relative to prescription drug pricing
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
895
|
An Act to promote transparency and prevent price gouging of pharmaceutical drug prices
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
4000
|
An Act making appropriations for the fiscal year 2026 for the maintenance of the departments, boards, commissions, institutions, and certain activities of the commonwealth, for interest, sinking fund, and serial bond requirements, and for certain permanent improvements
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
1274
|
An Act prohibiting PBMs from discriminating against hospitals and patients participating in the 340B drug discount program
|
Oppose
|
$0.00
|
N/A
|
|
House Bill
|
1326
|
An Act to ensure access to prescription medications
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
2035
|
An Act to eliminate the tax deduction for direct-to-consumer pharmaceutical marketing
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
3
|
An Act making appropriations for the fiscal year 2026 for the maintenance of the departments, boards, commissions, institutions, and certain activities of the commonwealth, for interest, sinking fund, and serial bond requirements, and for certain permanent improvements
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
1334
|
An Act to enact pharmacy benefit manager duties
|
Support
|
$0.00
|
N/A
|
|
Senate Bill
|
1583
|
An Act to restore integrity in the marketing of pharmaceutical products and medical devices
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
1136
|
An Act improving the health insurance prior authorization process
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
1107
|
An Act prohibiting discrimination against 340b drug discount program participants
|
Oppose
|
$0.00
|
N/A
|
|
Senate Bill
|
734
|
An Act ensuring access to specialty medications
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
2509
|
An Act relative to the availability of prescription medication during an emergency
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
2525
|
An Act making appropriations for the fiscal year 2026 for the maintenance of the departments, boards, commissions, institutions, and certain activities of the commonwealth, for interest, sinking fund, and serial bond requirements, and for certain permanent improvements
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
1234
|
An Act relative to pharmacy benefit managers
|
Support
|
$0.00
|
N/A
|
|
Senate Bill
|
1584
|
An Act to prevent undue influence on prescriber behavior
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
1
|
An Act making appropriations for the fiscal year 2026 for the maintenance of the departments, boards, commissions, institutions, and certain activities of the commonwealth, for interest, sinking fund, and serial bond requirements, and for certain permanent improvements
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
779
|
An Act to protect 340B providers in the MassHealth program
|
Oppose
|
$0.00
|
N/A
|
|
House Bill
|
1092
|
An Act to ensure affordable prescription medications through accountability standards
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
1368
|
An Act to provide rapid whole genome sequencing
|
Support
|
$0.00
|
N/A
|
|
House Bill
|
4150
|
An Act making appropriations for the fiscal year 2025 to provide for supplementing certain existing appropriations and for certain other activities and projects.
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
1296
|
An Act to protect 340B providers
|
Oppose
|
$0.00
|
N/A
|
|
House Bill
|
1322
|
An Act ensuring access to specialty medications
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
904
|
An Act to strengthen health spending accountability processes within the health policy commission and the center for health information and analysis
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
4240
|
An Act making appropriations for the fiscal year 2026 for the maintenance of the departments, boards, commissions, institutions and certain activities of the Commonwealth, for interest, sinking fund and serial bond requirements, and for certain permanent improvements
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
819
|
An Act prohibiting discrimination against 340b drug discount program participants
|
Oppose
|
$0.00
|
N/A
|
|
Senate Bill
|
694
|
An Act empowering health care consumers
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
1374
|
An Act establishing a state-wide drug repository program
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
2529
|
An Act making appropriations for the fiscal year 2025 to provide for supplementing certain existing appropriations and for certain other activities and projects.
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
779
|
An Act to protect 340B providers
|
Oppose
|
$0.00
|
N/A
|
|
House Bill
|
1325
|
An Act to ensure access to generic medication
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
1227
|
An Act relative to patient access to biomarker testing to provide appropriate therapy
|
Support
|
$0.00
|
N/A
|
|
House Bill
|
4151
|
An Act making appropriations for the fiscal year 2025 to provide for supplementing certain existing appropriations and for certain other activities and projects.
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
845
|
An Act to protect 340B providers in the Medicaid program
|
Oppose
|
$0.00
|
N/A
|
|
Senate Bill
|
875
|
An Act to promote transparency in prescription drug prices
|
Oppose
|
$0.00
|
N/A
|
|
Senate Bill
|
809
|
An Act relative to patient access to biomarker testing to provide appropriate therapy
|
Support
|
$0.00
|
N/A
|
|
Senate Bill
|
2540
|
An Act making appropriations for the fiscal year 2025 to provide for supplementing certain existing appropriations and for certain other activities and projects
|
Neutral
|
$0.00
|
N/A
|
| | | |
Total amount
|
$0.00
| |
|
|
Lobbyist: John F.X. Heffernan
|
|
Client:
Biotechnology Innovation Organization
|
|
|
|
House Bill
|
1334
|
An Act to enact pharmacy benefit manager duties
|
Support
|
$0.00
|
N/A
|
|
House Bill
|
1101
|
An Act relative to consumer deductibles
|
Support
|
$0.00
|
N/A
|
|
Senate Bill
|
1514
|
An Act relative to provider choice
|
Support
|
$0.00
|
N/A
|
|
Executive
|
Executive Office of Housing and Economic Development (EOHED)(Executive Office of Health and Human Services)
|
Initiatives in the life sciences industry around workforce training, investment tax credits, economic development incentive programs, R&D Tax credits, financing and Infrastructure grants. Massachusetts Life Sciences Center initiatives around internship programs, tax incentive programs, seed funding, and capital project grants.
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
1082
|
An Act to enact the pharmacy benefit manager compensation reform
|
Support
|
$0.00
|
N/A
|
|
House Bill
|
1080
|
An Act relative to copay assistance
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
847
|
An Act relative to rapid whole genome sequencing
|
Support
|
$0.00
|
N/A
|
|
House Bill
|
4003
|
An Act making appropriations for fiscal year 2025 to provide for supplementing certain existing appropriations and for certain other activities and projects
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
1167
|
An Act to enact pharmacy benefit manager duties
|
Support
|
$0.00
|
N/A
|
|
House Bill
|
4043
|
An Act relative to copay assistance for medications
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
2384
|
An Act relative to provider choice
|
Support
|
$0.00
|
N/A
|
|
Executive
|
Executive Office of Labor and Workforce Development (EOLWD)
|
Initiatives around workforce training in the life sciences industry, including but not limited to non-four-year degree pathways with hands-on experience, partnerships with minority serving Institutions, increasing career awareness in younger students, and centralizing workforce development efforts.
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
1296
|
An Act to protect 340B providers
|
Oppose
|
$0.00
|
N/A
|
|
Senate Bill
|
884
|
An Act to define modest meals and refreshments in prescriber education settings
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
4001
|
An Act making appropriations for the fiscal year 2026 for the maintenance of the departments, boards, commissions, institutions, and certain activities of the commonwealth, for interest, sinking fund, and serial bond requirements, and for certain permanent improvements
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
724
|
An Act promoting healthcare access and affordability for patients
|
Support
|
$0.00
|
N/A
|
|
House Bill
|
1324
|
An Act relative to prescription drug pricing
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
1384
|
An Act updating the health care cost growth benchmark and associated market oversight activities
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
693
|
An Act relative to non-medical switching
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
1234
|
An Act relative to pharmacy benefit managers
|
Support
|
$0.00
|
N/A
|
|
Senate Bill
|
698
|
An Act relative to consumer deductibles
|
Support
|
$0.00
|
N/A
|
|
House Bill
|
1125
|
An Act relative to non-medical switching
|
Neutral
|
$0.00
|
N/A
|
|
Executive
|
Office of the Governor
|
Regulations or policies pertaining to drug innovation, pharmaceuticals, recycling and disposal, provider and industry practices related to pharmaceuticals, drug pricing, drug transparency, prescribing, dispensing and monitoring controlled substances and related policies, patient access and prescribing.
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
1107
|
An Act prohibiting discrimination against 340b drug discount program participants
|
Oppose
|
$0.00
|
N/A
|
|
Senate Bill
|
895
|
An Act to promote transparency and prevent price gouging of pharmaceutical drug prices
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
4000
|
An Act making appropriations for the fiscal year 2026 for the maintenance of the departments, boards, commissions, institutions, and certain activities of the commonwealth, for interest, sinking fund, and serial bond requirements, and for certain permanent improvements
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
819
|
An Act prohibiting discrimination against 340b drug discount program participants
|
Oppose
|
$0.00
|
N/A
|
|
House Bill
|
1326
|
An Act to ensure access to prescription medications
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
2035
|
An Act to eliminate the tax deduction for direct-to-consumer pharmaceutical marketing
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
3
|
An Act making appropriations for the fiscal year 2026 for the maintenance of the departments, boards, commissions, institutions, and certain activities of the commonwealth, for interest, sinking fund, and serial bond requirements, and for certain permanent improvements
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
1364
|
An Act relative to promoting healthcare access and affordability for patients
|
Support
|
$0.00
|
N/A
|
|
Senate Bill
|
827
|
An Act to ensure access to prescription medications
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
1583
|
An Act to restore integrity in the marketing of pharmaceutical products and medical devices
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
1136
|
An Act improving the health insurance prior authorization process
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
779
|
An Act to protect 340B providers
|
Oppose
|
$0.00
|
N/A
|
|
Senate Bill
|
734
|
An Act ensuring access to specialty medications
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
2509
|
An Act relative to the availability of prescription medication during an emergency
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
2525
|
An Act making appropriations for the fiscal year 2026 for the maintenance of the departments, boards, commissions, institutions, and certain activities of the commonwealth, for interest, sinking fund, and serial bond requirements, and for certain permanent improvements
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
1274
|
An Act prohibiting PBMs from discriminating against hospitals and patients participating in the 340B drug discount program
|
Oppose
|
$0.00
|
N/A
|
|
Senate Bill
|
1584
|
An Act to prevent undue influence on prescriber behavior
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
1
|
An Act making appropriations for the fiscal year 2026 for the maintenance of the departments, boards, commissions, institutions, and certain activities of the commonwealth, for interest, sinking fund, and serial bond requirements, and for certain permanent improvements
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
785
|
An Act protecting 340B contract pharmacies
|
Oppose
|
$0.00
|
N/A
|
|
House Bill
|
1092
|
An Act to ensure affordable prescription medications through accountability standards
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
1368
|
An Act to provide rapid whole genome sequencing
|
Support
|
$0.00
|
N/A
|
|
House Bill
|
4150
|
An Act making appropriations for the fiscal year 2025 to provide for supplementing certain existing appropriations and for certain other activities and projects.
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
845
|
An Act to protect 340B providers in the Medicaid program
|
Oppose
|
$0.00
|
N/A
|
|
House Bill
|
1322
|
An Act ensuring access to specialty medications
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
904
|
An Act to strengthen health spending accountability processes within the health policy commission and the center for health information and analysis
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
4240
|
An Act making appropriations for the fiscal year 2026 for the maintenance of the departments, boards, commissions, institutions and certain activities of the Commonwealth, for interest, sinking fund and serial bond requirements, and for certain permanent improvements
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
779
|
An Act to protect 340B providers in the MassHealth program
|
Oppose
|
$0.00
|
N/A
|
|
Senate Bill
|
694
|
An Act empowering health care consumers
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
1374
|
An Act establishing a state-wide drug repository program
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
2529
|
An Act making appropriations for the fiscal year 2025 to provide for supplementing certain existing appropriations and for certain other activities and projects.
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
868
|
An Act enhancing health care market oversight and pharmaceutical access
|
Oppose
|
$0.00
|
N/A
|
|
House Bill
|
1325
|
An Act to ensure access to generic medication
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
1227
|
An Act relative to patient access to biomarker testing to provide appropriate therapy
|
Support
|
$0.00
|
N/A
|
|
House Bill
|
4151
|
An Act making appropriations for the fiscal year 2025 to provide for supplementing certain existing appropriations and for certain other activities and projects.
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
848
|
An Act relating to covered entity reporting to increase accountability to safeguard benefit for vulnerable patients
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
875
|
An Act to promote transparency in prescription drug prices
|
Oppose
|
$0.00
|
N/A
|
|
Senate Bill
|
809
|
An Act relative to patient access to biomarker testing to provide appropriate therapy
|
Support
|
$0.00
|
N/A
|
|
Senate Bill
|
2540
|
An Act making appropriations for the fiscal year 2025 to provide for supplementing certain existing appropriations and for certain other activities and projects
|
Neutral
|
$0.00
|
N/A
|
| | | |
Total amount
|
$0.00
| |
|
|
Lobbyist: John F.X. Heffernan
|
|
Client:
Sage Therapeutics, Inc.
|
|
|
|
House Bill
|
2224
|
An Act relative to improving mental health care through innovation
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
1407
|
Resolve to ensure delivery of mental health services to adults with acute mental illness
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
823
|
An Act enhancing post-pregnancy mental health care
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
709
|
An Act for supportive care for serious mental illness
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
1115
|
An Act to provide continuum of care for severe mental illness
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
1135
|
An Act for supportive care for serious mental illness
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
1801
|
An Act to provide continuum of care for severe mental illness
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
1314
|
An Act enhancing post-pregnancy mental health care
|
Support
|
$0.00
|
N/A
|
| | | |
Total amount
|
$0.00
| |
|
|
Lobbyist: John F.X. Heffernan
|
|
Client:
Acadia Pharmaceuticals Inc.
|
|
|
|
Senate Bill
|
868
|
An Act enhancing health care market oversight and pharmaceutical access
|
Oppose
|
$0.00
|
N/A
|
|
Senate Bill
|
724
|
An Act promoting healthcare access and affordability for patients
|
Support
|
$0.00
|
N/A
|
|
House Bill
|
1364
|
An Act relative to promoting healthcare access and affordability for patients
|
Support
|
$0.00
|
N/A
|
|
Senate Bill
|
875
|
An Act to promote transparency in prescription drug prices
|
Oppose
|
$0.00
|
N/A
|
| | | |
Total amount
|
$0.00
| |
|
|
Lobbyist: John F.X. Heffernan
|
|
Senate Bill
|
875
|
An Act to promote transparency in prescription drug prices
|
Oppose
|
$0.00
|
N/A
|
|
House Bill
|
1101
|
An Act relative to consumer deductibles
|
Support
|
$0.00
|
N/A
|
|
Senate Bill
|
724
|
An Act promoting healthcare access and affordability for patients
|
Support
|
$0.00
|
N/A
|
|
House Bill
|
1334
|
An Act to enact pharmacy benefit manager duties
|
Support
|
$0.00
|
N/A
|
|
House Bill
|
1364
|
An Act relative to promoting healthcare access and affordability for patients
|
Support
|
$0.00
|
N/A
|
|
House Bill
|
1234
|
An Act relative to pharmacy benefit managers
|
Support
|
$0.00
|
N/A
|
|
Senate Bill
|
779
|
An Act to protect 340B providers
|
Oppose
|
$0.00
|
N/A
|
|
House Bill
|
1274
|
An Act prohibiting PBMs from discriminating against hospitals and patients participating in the 340B drug discount program
|
Oppose
|
$0.00
|
N/A
|
|
House Bill
|
1227
|
An Act relative to patient access to biomarker testing to provide appropriate therapy
|
Support
|
$0.00
|
N/A
|
|
Senate Bill
|
868
|
An Act enhancing health care market oversight and pharmaceutical access
|
Oppose
|
$0.00
|
N/A
|
|
Senate Bill
|
698
|
An Act relative to consumer deductibles
|
Support
|
$0.00
|
N/A
|
|
Senate Bill
|
819
|
An Act prohibiting discrimination against 340b drug discount program participants
|
Oppose
|
$0.00
|
N/A
|
|
Senate Bill
|
845
|
An Act to protect 340B providers in the Medicaid program
|
Oppose
|
$0.00
|
N/A
|
|
House Bill
|
1107
|
An Act prohibiting discrimination against 340b drug discount program participants
|
Oppose
|
$0.00
|
N/A
|
|
Senate Bill
|
809
|
An Act relative to patient access to biomarker testing to provide appropriate therapy
|
Support
|
$0.00
|
N/A
|
|
House Bill
|
779
|
An Act to protect 340B providers in the MassHealth program
|
Oppose
|
$0.00
|
N/A
|
|
House Bill
|
1296
|
An Act to protect 340B providers
|
Oppose
|
$0.00
|
N/A
|
|
House Bill
|
1187
|
An Act relative to increasing consumer access to licensed rehabilitation counselors
|
Support
|
$0.00
|
N/A
|
|
Senate Bill
|
868
|
An Act enhancing health care market oversight and pharmaceutical access
|
Oppose
|
$0.00
|
N/A
|
|
House Bill
|
785
|
An Act protecting 340B contract pharmacies
|
Oppose
|
$0.00
|
N/A
|
|
Senate Bill
|
848
|
An Act relating to covered entity reporting to increase accountability to safeguard benefit for vulnerable patients
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
1082
|
An Act to enact the pharmacy benefit manager compensation reform
|
Support
|
$0.00
|
N/A
|
| | | |
Total amount
|
$0.00
| |
|
|
Lobbyist: John F.X. Heffernan
|
|
House Bill
|
779
|
An Act to protect 340B providers in the MassHealth program
|
Oppose
|
$0.00
|
N/A
|
|
Senate Bill
|
779
|
An Act to protect 340B providers
|
Oppose
|
$0.00
|
N/A
|
|
Senate Bill
|
845
|
An Act to protect 340B providers in the Medicaid program
|
Oppose
|
$0.00
|
N/A
|
|
Senate Bill
|
724
|
An Act promoting healthcare access and affordability for patients
|
Support
|
$0.00
|
N/A
|
|
House Bill
|
1334
|
An Act to enact pharmacy benefit manager duties
|
Support
|
$0.00
|
N/A
|
|
House Bill
|
785
|
An Act protecting 340B contract pharmacies
|
Oppose
|
$0.00
|
N/A
|
|
Senate Bill
|
868
|
An Act enhancing health care market oversight and pharmaceutical access
|
Oppose
|
$0.00
|
N/A
|
|
Senate Bill
|
693
|
An Act relative to non-medical switching
|
Support
|
$0.00
|
N/A
|
|
House Bill
|
1187
|
An Act relative to increasing consumer access to licensed rehabilitation counselors
|
Support
|
$0.00
|
N/A
|
|
House Bill
|
1364
|
An Act relative to promoting healthcare access and affordability for patients
|
Support
|
$0.00
|
N/A
|
|
House Bill
|
1234
|
An Act relative to pharmacy benefit managers
|
Support
|
$0.00
|
N/A
|
|
Senate Bill
|
848
|
An Act relating to covered entity reporting to increase accountability to safeguard benefit for vulnerable patients
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
875
|
An Act to promote transparency in prescription drug prices
|
Oppose
|
$0.00
|
N/A
|
|
House Bill
|
1101
|
An Act relative to consumer deductibles
|
Support
|
$0.00
|
N/A
|
|
House Bill
|
1125
|
An Act relative to non-medical switching
|
Support
|
$0.00
|
N/A
|
|
House Bill
|
1082
|
An Act to enact the pharmacy benefit manager compensation reform
|
Support
|
$0.00
|
N/A
|
|
Senate Bill
|
819
|
An Act prohibiting discrimination against 340b drug discount program participants
|
Oppose
|
$0.00
|
N/A
|
|
Senate Bill
|
868
|
An Act enhancing health care market oversight and pharmaceutical access
|
Oppose
|
$0.00
|
N/A
|
|
Senate Bill
|
698
|
An Act relative to consumer deductibles
|
Support
|
$0.00
|
N/A
|
|
House Bill
|
1274
|
An Act prohibiting PBMs from discriminating against hospitals and patients participating in the 340B drug discount program
|
Oppose
|
$0.00
|
N/A
|
|
House Bill
|
1227
|
An Act relative to patient access to biomarker testing to provide appropriate therapy
|
Support
|
$0.00
|
N/A
|
|
House Bill
|
1107
|
An Act prohibiting discrimination against 340b drug discount program participants
|
Oppose
|
$0.00
|
N/A
|
|
Senate Bill
|
809
|
An Act relative to patient access to biomarker testing to provide appropriate therapy
|
Support
|
$0.00
|
N/A
|
|
House Bill
|
1296
|
An Act to protect 340B providers
|
Oppose
|
$0.00
|
N/A
|
| | | |
Total amount
|
$0.00
| |
|
|
Lobbyist: John F.X. Heffernan
|
|
Client:
Acuity Strategic Partners LLC
|
|
|
|
Executive
|
Other
|
No lobbying activities conducted.
|
Neutral
|
$0.00
|
N/A
|
| | | |
Total amount
|
$0.00
| |
|
|
|
|
Meals, Travel, and Entertainment Expenses
|
| No meals, travel, or entertainment expenses were filed for this disclosure reporting period. |
|
| |
|
Additional Expenses
|
| No additional expenses were filed for this disclosure reporting period. |
|
| |
|
Campaign Contributions
|
| 01/27/2025 | John F.X. Heffernan |
Aaron Michlewitz
|
State Representative, 3rd Suffolk
|
$200.00
|
| 01/27/2025 | John F.X. Heffernan |
Meghan Kilcoyne
|
State Representative, 12th Worcester
|
$200.00
|
| 02/25/2025 | John F.X. Heffernan |
Paul Donato
|
State Representative, 35th Middlesex
|
$200.00
|
| 03/04/2025 | John F.X. Heffernan |
Ronald Mariano
|
State Representative, 3rd Norfolk
|
$200.00
|
| 03/05/2025 | John F.X. Heffernan |
James Murphy
|
State Representative, 4th Norfolk
|
$200.00
|
| 03/18/2025 | John F.X. Heffernan |
Bill MacGregor
|
State Representative, 10th Suffolk
|
$200.00
|
| 03/26/2025 | John F.X. Heffernan |
John Mahoney
|
State Representative, 13th Worcester
|
$200.00
|
| 03/26/2025 | John F.X. Heffernan |
Karen Spilka
|
State Senate, Middlesex and Norfolk
|
$200.00
|
| 03/31/2025 | John F.X. Heffernan |
Mike Rush
|
State Senate, Norfolk and Suffolk
|
$200.00
|
| 04/03/2025 | John F.X. Heffernan |
David Biele
|
State Representative, 4th Suffolk
|
$200.00
|
| 04/08/2025 | John F.X. Heffernan |
Dan Cahill
|
State Representative, 10th Essex
|
$200.00
|
| 04/08/2025 | John F.X. Heffernan |
Mark Cusack
|
State Representative, 5th Norfolk
|
$200.00
|
| 04/09/2025 | John F.X. Heffernan |
Christopher Worrell
|
State Representative, 5th Suffolk
|
$200.00
|
| 04/15/2025 | John F.X. Heffernan |
John Lawn
|
State Representative, 10th Middlesex
|
$200.00
|
| 04/15/2025 | John F.X. Heffernan |
Nick Collins
|
State Senate, First Suffolk
|
$200.00
|
| 04/15/2025 | John F.X. Heffernan |
Jeffrey Roy
|
State Representative, 10th Norfolk
|
$200.00
|
| 04/15/2025 | John F.X. Heffernan |
Marjorie Decker
|
State Representative, 25th Middlesex
|
$200.00
|
| 04/15/2025 | John F.X. Heffernan |
Danielle Gregoire
|
State Representative, 4th Middlesex
|
$200.00
|
| 04/15/2025 | John F.X. Heffernan |
Carole Fiola
|
State Representative, 6th Bristol
|
$200.00
|
| 04/15/2025 | John F.X. Heffernan |
Alice Peisch
|
State Representative, 14th Norfolk
|
$200.00
|
| 04/15/2025 | John F.X. Heffernan |
Jack Lewis
|
State Representative, 7th Middlesex
|
$200.00
|
| 04/17/2025 | John F.X. Heffernan |
Jessica Giannino
|
State Representative, 16th Suffolk
|
$200.00
|
| 04/28/2025 | John F.X. Heffernan |
Dave Rogers
|
State Representative, 24th Middlesex
|
$200.00
|
| 05/20/2025 | John F.X. Heffernan |
Aaron Saunders
|
State Representative, 7th Hampden
|
$200.00
|
| 05/22/2025 | John F.X. Heffernan |
Joe McGonagle
|
State Representative, 28th Middlesex
|
$200.00
|
| 05/31/2025 | John F.X. Heffernan |
Maura Healey
|
Governor, Commonwealth of Massachusetts
|
$200.00
|
| 06/03/2025 | John F.X. Heffernan |
Ann-Margaret Ferrante
|
State Representative, 5th Essex
|
$200.00
|
| 06/25/2025 | John F.X. Heffernan |
Dan Hunt
|
State Representative, 13th Suffolk
|
$200.00
|
| | | | Total contributions |
$5,600.00
|
|
|
|
|
|